A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity

Genome Research

Volumn 23, Issue 6, 2013, Pages 917-927

  Zhang, Bing ^a   Day, Daniel S ^b,c   Ho, Joshua W ^b   Song, Lingyun ^d   Cao, Jingjing ^a   Christodoulou, Danos ^e   Seidman, Jonathan G ^e   Crawford, Gregory E ^d   Park, Peter J ^b   Pu, William T ^a,f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Harvard Medical School Center for Biomedical Informatics   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d DUKE UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; E1A ASSOCIATED P300 PROTEIN; HISTONE H3; VASCULOTROPIN A;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONFORMATION; CONTROLLED STUDY; EPIGENETICS; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HISTONE ACETYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ACETYLATION; BINDING SITES; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLUSTER ANALYSIS; E1A-ASSOCIATED P300 PROTEIN; ENDOTHELIAL CELLS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NUCLEOTIDE MOTIFS; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878679046     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.149674.112     Document Type: Article

References (39)

1. Altarejos JY, Montminy M. 2011. CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12: 141-151.
2. Bailey TL. 2011. DREME: Motif discovery in transcription factor ChIP-seq data. Bioinformatics 27: 1653-1659.
3. Bonn S, Zinzen RP, Girardot C, Gustafson EH, Perez-Gonzalez A, Delhomme N, Ghavi-Helm Y, Wilczynski B, Riddell A, Furlong EE. 2012. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet 44: 148-156.
4. Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H, et al. 2010. Virtual ligand screening of the p300/CBP histone acetyltransferase: Identification of a selective small molecule inhibitor. Chem Biol 17: 471-482.
5. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS, Crawford GE. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322. (Pubitemid 351172431)
6. Carmeliet P, Jain RK. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature 473: 298-307.
7. Christodoulou DC, Gorham JM, Herman DS, Seidman JG. 2011. Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease. Curr Protoc Mol Biol 94: 4.12.1-4.12.11.
8. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci 107: 21931-21936.
9. D'Angelo G, Struman I, Martial J, Weiner RI. 1995. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci 92: 6374-6378.
10. De Val S, Chi NC, Meadows SM, Minovitsky S, Anderson JP, Harris IS, Ehlers ML, Agarwal P, Visel A, Xu SM, et al. 2008. Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell 135: 1053-1064.
11. Dekker J, Rippe K, Dekker M, Kleckner N. 2002. Capturing chromosome conformation. Science 295: 1306-1311. (Pubitemid 34157624)
12. Ernst J, Kheradpour P, Mikkelsen TJ, Shoresh N,Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, et al. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49.
13. Gupta S, Stamatoyannopoulos JA, Bailey TL, Noble WS. 2007. Quantifying similarity between motifs. Genome Biol 8: R24.
14. Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, de LaatW, Forne T. 2007. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2: 1722-1733.
15. He HH, Meyer CA, Shin H, Bailey ST,Wei G,Wang Q, Zhang Y, Xu K, Ni M, Lupien M, et al. 2010. Nucleosome dynamics define transcriptional enhancers. Nat Genet 42: 343-347.
16. Heintzman ND, Stuart RK, Hon G, Fu Y, ChingCW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318. (Pubitemid 46328487)
17. Hellstrom M, Phng LK, Gerhardt H. 2007. VEGF and Notch signaling: The yin and yang of angiogenic sprouting. Cell Adhes Migr 1: 133-136.
18. Holderfield MT, Hughes CC. 2008. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-b in vascular morphogenesis. Circ Res 102: 637-652. (Pubitemid 351457853)
19. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, et al. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467: 430-435.
20. Kharchenko PV, TolstorukovMY, Park PJ. 2008. Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat Biotechnol 26: 1351-1359.
21. Kharchenko PV, Alekseyenko AA, Schwartz YB, Minoda A, Riddle NC, Ernst J, Sabo PJ, Larschan E, Gorchakov AA, Gu T, et al. 2011. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature 471: 480-485.
22. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin DA, Laptewicz M, Barbara-Haley K, Kuersten S, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182-187.
23. Kundaje A, Kyriazopoulou-Panagiotopoulou S, Libbrecht M, Smith CL, Raha D, Winters EE, Johnson SM, Snyder M, Batzoglou S, Sidow A. 2012. Ubiquitous heterogeneity and asymmetry of the chromatin environment at regulatory elements. Genome Res 22: 1735-1747.
24. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
25. Lee TI, Johnstone SE, Young RA. 2006. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 1: 729-748.
26. Linnemann AK, O'Geen H, Keles S, FarnhamPJ, Bresnick EH. 2011. Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci 108: 13641-13646.
27. Liu X, Zhao D, James L, Li J, Zeng H. 2011. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor. FASEB J 25: 1188-1197.
28. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959. (Pubitemid 26404293)
29. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279-283.
30. Randi AM, Sperone A, Dryden NH, Birdsey GM. 2009. Regulation of angiogenesis by ETS transcription factors. Biochem Soc Trans 37: 1248-1253.
31. Reddy TE, Gertz J, Pauli F, Kucera KS, Varley KE, Newberry KM, Marinov GK, Mortazavi A, Williams BA, Song L, et al. 2012. Effects of sequence variation on differential allelic transcription factor occupancy and gene expression. Genome Res 22: 860-869.
32. Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H,Wagner O, Bilban M, Hofer E. 2009. The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 102: 544-554.
33. Song L, Crawford GE. 2010. DNase-seq: A high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc doi: 10.1101/pdb.prot5384.
34. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. 2002. Looping and interaction between hypersensitive sites in the active b-globin locus. Mol Cell 10: 1453-1465. (Pubitemid 36050885)
35. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
36. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
37. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, Qiu J, Liu W, Kaikkonen MU, Ohgi KA, et al. 2011. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474: 390-394.
38. Xi H, Shulha HP, Lin JM, Vales TR, Fu Y, Bodine DM, McKay RDG, Chenoweth JG, Tesar PJ, Furey TS, et al. 2007. Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet 3: e136.
39. Zentner GE, Tesar PJ, Scacheri PC. 2011. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 21: 1273-1283.